Cargando…

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis

Patient assessment of disease activity in rheumatoid arthritis (RA) may be useful in clinical practice, offering a patient-friendly, location independent, and a time-efficient and cost-efficient means of monitoring the disease. The objective of this study was to identify patient-reported outcome mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrikx, Jos, de Jonge, Marieke J, Fransen, Jaap, Kievit, Wietske, van Riel, Piet LCM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013514/ https://www.ncbi.nlm.nih.gov/pubmed/27651921 http://dx.doi.org/10.1136/rmdopen-2015-000202

Ejemplares similares

Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare
por: Hendrikx, Jos, et al.
Publicado: (2015)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
por: Vermeer, Marloes, et al.
Publicado: (2013)

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
por: Manders, Sofie HM, et al.
Publicado: (2015)

Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis
por: Toonen, Erik JM, et al.
Publicado: (2012)

The relationship between change in subjective outcome and change in disease: a potential paradox
por: Kievit, Wietske, et al.
Publicado: (2010)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial
por: Ferwerda, Maaike, et al.
Publicado: (2018)

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts
por: Weijers, Julia M., et al.
Publicado: (2018)

A Replication Study of the Association between Rheumatoid Arthritis and Deletion of the Late Cornified Envelope Genes LCE3B and LCE3C
por: Bergboer, Judith G. M., et al.
Publicado: (2012)

Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
por: Toonen, Erik J. M., et al.
Publicado: (2012)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
por: Flendrie, Marcel, et al.
Publicado: (2005)

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis
por: Siemons, Liseth, et al.
Publicado: (2014)

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
por: Arts, Elke, et al.
Publicado: (2012)

Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis
por: Plantinga, Theo S, et al.
Publicado: (2010)

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
por: Vermeer, Marloes, et al.
Publicado: (2012)

Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome
por: Coenen, Marieke J. H., et al.
Publicado: (2010)

Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis
por: ten Klooster, Peter M, et al.
Publicado: (2013)

Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time
por: van der Willik, Esmee M., et al.
Publicado: (2020)

Immune responses to stress after stress management training in patients with rheumatoid arthritis
por: de Brouwer, Sabine JM, et al.
Publicado: (2013)

Two parallel short forms to measure disease- and treatment-associated knowledge in rheumatoid arthritis: application of item response theory
por: Spijk-de Jonge, Marieke J, et al.
Publicado: (2020)

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)
por: Haywood, Kirstie L, et al.
Publicado: (2017)

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
por: van den Bemt, Bart JF, et al.
Publicado: (2011)

Patient-Reported Outcome Measures (PROM) as A Preoperative Assessment Tool
por: Kim, Sunghye, et al.
Publicado: (2017)

IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis
por: Damen, Michelle S. M. A., et al.
Publicado: (2017)

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
por: Beretta, Lorenzo, et al.
Publicado: (2010)

Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review
por: Gabes, Michaela, et al.
Publicado: (2021)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Co-Design of a Disease Activity Based Self-Management Approach for Patients with Rheumatoid Arthritis
por: Spijk-de Jonge, Marieke J., et al.
Publicado: (2021)

A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis
por: Ratnayake, Irushi, et al.
Publicado: (2020)

Patient-reported outcome measures (PROMs) after laparoscopic cholecystectomy: systematic review
por: Melly, Conor, et al.
Publicado: (2022)

Addressing Missing Data in Patient‐Reported Outcome Measures (PROMS): Implications for the Use of PROMS for Comparing Provider Performance
por: Gomes, Manuel, et al.
Publicado: (2015)

The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries
por: Hewlett, Sarah, et al.
Publicado: (2018)

Systematic review and standardised assessment of Chinese cross-cultural adapted hip Patient Reported Outcome Measures (PROMs)
por: Ngwayi, James Reeves Mbori, et al.
Publicado: (2021)

Patient reported outcome measures (PROMS) for body image in dermatology: A systematic review
por: Kristensen, Johannes Kjeldstrup, et al.
Publicado: (2022)

A catalogue of PROMs in sports science: Quality assessment of PROM development and validation
por: Hansen, Christian F., et al.
Publicado: (2021)

Uses and Abuses of Patient Reported Outcome Measures (PROMs): Potential Iatrogenic Impact of PROMs Implementation and How It Can Be Mitigated
por: Wolpert, Miranda
Publicado: (2013)

Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial
por: Hernar, Ingvild, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pk3jlqmol7ijucj09k938b3cb6